Patents by Inventor Theo Schotten

Theo Schotten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ZWITTERIONIC NANOPARTICLES
    Publication number: 20230160902
    Abstract: Furthermore, the present invention relates to a composition, a method of binding a zwitterionic nanoparticle and the use of a zwitterionic nanoparticle.
    Type: Application
    Filed: November 21, 2022
    Publication date: May 25, 2023
    Inventors: Joerg HEEREN, Alexander FISCHER, Theo SCHOTTEN, Michaela STEUTER, Jan-Philip MERKL, Horst WELLER
  • ZWITTERIONIC NANOPARTICLES
    Publication number: 20190369107
    Abstract: The present invention relates to a zwitterionic nanoparticle, the zwitterionic nanoparticle comprising at least one nanoparticle and a zwitterionic case enclosing the nanoparticle. Furthermore, the present invention relates to a composition, a method of binding a zwitterionic nanoparticle and the use of a zwitterionic nanoparticle.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 5, 2019
    Inventors: Theo SCHOTTEN, Michaela STEUTER, Jan-Philip MERKL, Horst WELLER
  • ZWITTERIONIC NANOPARTICLES
    Publication number: 20190367807
    Abstract: The present invention relates to a zwitterionic nanoparticle, the zwitterionic nanoparticle comprising at least one nanoparticle and a zwitterionic case enclosing the nanoparticle. Furthermore, the present invention relates to a composition, a method of binding a zwitterionic nanoparticle and the use of a zwitterionic nanoparticle.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 5, 2019
    Inventors: Joerg HEEREN, Alexander FISCHER, Theo SCHOTTEN, Michaela STEUTER, Jan-Philip MERKL, Horst WELLER
  • Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use
    Patent number: 10357751
    Abstract: The present invention relates to a composition, comprising at least one micelle in non-aqueous solution, wherein the micelle encapsules one or more nanoparticle(s) and wherein the micelle comprises a cross-linked hydrophilic shell. Furthermore, the present invention relates to the use of such a composition and to methods for providing such a composition.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: July 23, 2019
    Assignee: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Theo Schotten, Katja Werner, Carsten Ott, Jan Steffen Niehaus, Marieke Dieckmann, Horst Weller, Johannes Ostermann, Christoph Hahn
  • Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use
    Patent number: 10315178
    Abstract: The present invention relates to a composition, comprising at least one micelle in non-aqueous solution, wherein the micelle encapsules one or more nanoparticles. Furthermore, the present invention relates to the use of such a composition and to methods for providing such a composition.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: June 11, 2019
    Assignee: FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Theo Schotten, Katja Werner, Carsten Ott, Jan Steffen Niehaus, Marieke Dieckmann, Horst Weller, Johannes Ostermann, Christoph Hahn
  • POLYMER MICELLES CONTAINING NANOPARTICLES IN NON-AQUEOUS SOLUTION, METHODS FOR THEIR PREPARATION AND USE
    Publication number: 20170225140
    Abstract: The present invention relates to a composition, comprising at least one micelle in non-aqueous solution, wherein the micelle encapsules one or more nanoparticles. Furthermore, the present invention relates to the use of such a composition and to methods for providing such a composition.
    Type: Application
    Filed: October 13, 2015
    Publication date: August 10, 2017
    Inventors: Theo SCHOTTEN, Katja WERNER, Carsten OTT, Jan Steffen NIEHAUS, Marieke DIECKMANN, Horst WELLER, Johannes OSTERMANN, Christoph HAHN
  • POLYMER MICELLES CONTAINING NANOPARTICLES IN NON-AQUEOUS SOLUTION, METHODS FOR THEIR PREPARATION AND USE
    Publication number: 20170225141
    Abstract: The present invention relates to a composition, comprising at least one micelle in non-aqueous solution, wherein the micelle encapsules one or more nanoparticle(s) and wherein the micelle comprises a cross-linked hydrophilic shell. Furthermore, the present invention relates to the use of such a composition and to methods for providing such a composition.
    Type: Application
    Filed: October 13, 2015
    Publication date: August 10, 2017
    Inventors: Theo SCHOTTEN, Katja WERNER, Carsten OTT, Jan Steffen NIEHAUS, Marieke DIECKMANN, Horst WELLER, Johannes OSTERMANN, Christoph HAHN
  • ?adrenergic agonists
    Patent number: 7265127
    Abstract: The present invention relates to 2-imidazo[1,2-a]pyridine group containing ?3 adrenergic receptor agonists or pharmaceutical salts thereof.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: September 4, 2007
    Assignee: Eli Lilly and Company
    Inventors: Jolie Anne Bastian, Gerd Ruehter, Daniel Jon Sall, Theo Schotten
  • ?adrenergic agonists
    Patent number: 7253181
    Abstract: The present invention relates to pyrrolopyridine-3-yl group containing ?3 adrenergic receptor agonists or pharmaceutical salts thereof.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: August 7, 2007
    Assignee: Eli Lilly and Company
    Inventors: Jolie Anne Bastian, Gerd Ruehter, Daniel Jon Sall, Theo Schotten
  • ?adrenergic agonists
    Patent number: 7241772
    Abstract: The present invention relates to 2-imidazo[1,5-a]pyridine containing ?3 adrenergic receptor agonists or pharmaceutical salts thereof.
    Type: Grant
    Filed: February 17, 2006
    Date of Patent: July 10, 2007
    Assignee: Eli Lilly and Company
    Inventors: Jolie Anne Bastian, Gerd Ruehter, Daniel Jon Sall, Theo Schotten
  • Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
    Patent number: 7229987
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
    Type: Grant
    Filed: May 6, 2003
    Date of Patent: June 12, 2007
    Assignee: Eli Lilly and Company
    Inventors: Jochen Ammenn, James Ronald Gillig, Lawrence Joseph Heinz, Philip Arthur Hipskind, Michael Dean Kinnick, Yen-Shi Lai, John Michael Morin, Jr., James Arthur Nixon, Carsten Ott, Kenneth Allen Savin, Theo Schotten, Lawrence John Slieker, Nancy June Snyder, Michael Alan Robertson
  • ?3 adrenergic agonists
    Patent number: 7208505
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful, e.g.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: April 24, 2007
    Assignee: Eli Lilly and Company
    Inventors: Daniel Jon Sall, Jolie Anne Bastian, Rushad Eruch Karanjawala, Cynthia Darshini Jesudason, Theo Schotten, Britta Evers, Gerd Reuhter, Don Richard Finley, Freddie Craig Stevens, Vincent Patrick Rocco, Patrick Gianpietro Spinazze, John Xiaoqiang He, John Arnold Werner, William George Trankle, Andrew Michael Ratz
  • 3-Substituted oxindole ?3 agonists
    Patent number: 7205407
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of Formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: April 17, 2007
    Assignee: Eli Lilly and Company
    Inventors: Jolie Anne Bastian, Gerd Ruehter, Daniel Jon Sall, Theo Schotten
  • 3-substituted oxindole ?3 agonists
    Patent number: 7087635
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.
    Type: Grant
    Filed: March 16, 2005
    Date of Patent: August 8, 2006
    Assignee: Eli Lilly and Company
    Inventors: Daniel Jon Sall, Jolie Anne Bastian, Cynthia Darshini Jesudason, Don Richard Finley, Freddie Craig Stevens, Vincent Patrick Rocco, Patrick Gianpietro Spinazze, John Xiaoqiang He, John Arnold Werner, William George Trankle, Andrew Michael Ratz, Theo Schotten, Gerd Reuhter
  • ?Adrenergic agonists
    Patent number: 7071208
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: July 4, 2006
    Assignee: Eli Lilly and Company
    Inventors: Jolie Anne Bastian, Gerd Ruehter, Daniel Jon Sall, Theo Schotten
  • BETA 3 ADRENERGIC AGONISTS
    Publication number: 20060142329
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.
    Type: Application
    Filed: February 17, 2006
    Publication date: June 29, 2006
    Inventors: Jolie Bastian, Gerd Ruehter, Daniel Sall, Theo Schotten
  • BETA 3 ADRENERGIC AGONISTS
    Publication number: 20060142328
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.
    Type: Application
    Filed: February 17, 2006
    Publication date: June 29, 2006
    Inventors: Jolie Bastian, Gerd Ruehter, Daniel Sall, Theo Schotten
  • BETA 3 ADRENERGIC AGONISTS
    Publication number: 20060142327
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (1) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.
    Type: Application
    Filed: February 17, 2006
    Publication date: June 29, 2006
    Inventors: Jolie Bastian, Gerd Ruehter, Daniel Sall, Theo Schotten
  • Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
    Publication number: 20050272718
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
    Type: Application
    Filed: May 6, 2003
    Publication date: December 8, 2005
    Inventors: Jochen Ammenn, James Gillig, Lawrence Heinz, Philip Hipskind, Michael Kinnick, Yen-Shi Lai, John Morin, James Nixon, Carsten Ott, Kenneth Savin, Theo Schotten, Lawrence Slieker, Nancy Snyder, Michael Robertson
  • 3-Substituted oxindole beta3 agonists
    Publication number: 20050159473
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.
    Type: Application
    Filed: March 16, 2005
    Publication date: July 21, 2005
    Inventors: Daniel Sall, Jolie Bastian, Cynthia Jesudason, Don Finley, Freddie Stevens, Vincent Rocco, Patrick Spinazze, John He, John Werner, William Trankle, Andrew Ratz, Theo Schotten, Gerd Reuhter